Qmera Pharmaceuticals

Qmera Pharmaceuticals is a specialized CRO focused on high-resolution mass spectrometry (HRMS) to support early-stage drug development. Based in Research Triangle Park, North Carolina, we provide services in bioanalysis, drug metabolism & pharmacokinetics (DMPK), analytical chemistry, and pre-formulation support. Our scientists have decades of collective experience designing and executing studies that help clients characterize metabolic pathways, support PK profiling, and interpret complex bioanalytical data across discovery and preclinical stages. We support both small and large molecule programs across discovery and preclinical stages. Qmera was founded in 2021 to address common inefficiencies in early development. Our goal is to help biopharma partners move faster by delivering flexible, scientifically rigorous solutions that support confident decision-making. For more information, please visit www.qmerapharma.com.